Unlocking the Potential of a Powerful Medication | GLP-1s Exposed
30 May 2025 · 1 min

0:58
A short transcript excerpt from a May 30, 2025 YouTube video by Aaron Hartman, MD discussing GLP-1–class medications (e.g., semaglutide, tazeplatide), administration routes (injectable vs oral), dosing/cost considerations, and related agents such as berberine and metformin. The speaker links these medications and supplements to changes in metabolism via effects on the gut microbiome (noting increased Akkermansia muciniphila) and highlights potential therapeutic promise alongside dosing complexity.










